🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,36 USD

Máx. histórico

156,45

69 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,17%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-0,78%

Cierre anterior

149,52

Rango de hoy

147,12 – 150,25

Volumen hoy

9.050.917

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
149,86 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
159,91 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 17 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
14/03/2019 0,5248 USD
14/12/2018 0,5248 USD
14/09/2018 0,4580 USD
14/06/2018 0,4580 USD
14/03/2018 0,4580 USD
14/12/2017 0,4580 USD
14/09/2017 0,4485 USD
13/06/2017 0,4485 USD
13/03/2017 0,4485 USD
13/12/2016 0,4485 USD
13/09/2016 0,4389 USD
13/06/2016 0,4389 USD
11/03/2016 0,4389 USD
11/12/2015 0,4389 USD
11/09/2015 0,4294 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/09/2026 146,79 150,49 145,60 149,50 +1,79% 3,33% 7.992.700
18/09/2026 147,08 147,84 145,74 146,87 -0,19% 1,43% 31.159.700
17/09/2026 145,74 147,65 145,32 147,15 +1,55% 1,60% 11.060.600
16/09/2026 143,96 144,97 143,50 144,91 +0,78% 1,02% 7.226.900
15/09/2026 143,85 144,15 142,32 143,79 -0,73% 1,27% 8.291.600
14/09/2026 146,42 147,09 144,10 144,85 +0,64% 2,04% 7.412.500
11/09/2026 145,52 145,90 143,68 143,93 -0,54% 1,53% 8.678.200
10/09/2026 147,94 148,00 144,10 144,71 -1,91% 2,64% 7.542.000
09/09/2026 148,96 149,41 147,18 147,53 -0,63% 1,50% 8.546.000
08/09/2026 148,41 149,60 146,28 148,46 -1,24% 2,24% 11.187.000
04/09/2026 150,83 152,22 150,09 150,33 -1,32% 1,41% 4.395.400
03/09/2026 152,80 152,80 148,90 152,34 +0,46% 2,55% 6.498.300
02/09/2026 151,50 152,69 149,97 151,64 +1,19% 1,80% 8.969.200
01/09/2026 150,23 151,68 148,55 149,86 +1,42% 2,08% 9.865.600
31/08/2026 147,00 148,69 145,95 147,76 -0,40% 1,86% 11.124.700
28/08/2026 146,72 149,01 145,75 148,35 -0,80% 2,22% 8.067.000
27/08/2026 149,53 152,08 149,02 149,54 -2,33% 2,05% 8.522.600
26/08/2026 154,35 155,19 152,61 153,10 -2,14% 1,67% 8.627.600
25/08/2026 151,00 156,92 150,66 156,45 +3,84% 4,15% 14.005.100
24/08/2026 150,72 151,52 149,14 150,66 -1,24% 1,58% 15.032.000
21/08/2026 149,12 154,49 148,59 152,55 +2,39% 3,96% 15.976.200
20/08/2026 150,78 152,52 148,52 148,99 -2,11% 2,65% 16.204.700
19/08/2026 146,94 153,50 144,90 152,20 +12,60% 5,85% 32.776.300
18/08/2026 137,24 137,98 134,88 135,17 -0,59% 2,26% 10.284.200
17/08/2026 134,95 137,17 134,55 135,97 +0,10% 1,94% 8.477.300
14/08/2026 134,43 135,97 133,40 135,84 +0,21% 1,91% 6.869.000
13/08/2026 133,86 135,68 133,06 135,55 +1,98% 1,96% 8.895.200
12/08/2026 130,25 134,06 128,91 132,92 +1,92% 3,95% 10.447.100
11/08/2026 129,93 132,84 129,70 130,42 -0,38% 2,42% 6.342.200
10/08/2026 128,29 130,98 128,24 130,92 +1,82% 2,14% 6.007.600